Valeria Herdea | Medicine and Health Sciences | Cross-disciplinary Excellence Award

Published on by Research Hypothesis

Dr. Valeria Herdea | Medicine and Health Sciences | Cross-disciplinary Excellence Award

Dr. Valeria Herdea | Medicine and Health Sciences | Senior Consultant Family Medicine at George Emil Palade University of Medicine | Romania

Dr. Valeria Herdea is a dedicated medical academic and researcher specializing in pediatrics, with a strong focus on advancing child health through evidence-based research and responsible medical communication. She is affiliated with the George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, where her education and advanced academic training have provided a solid foundation in clinical pediatrics, public health, and research methodology. Her professional experience includes active involvement in academic research, scholarly writing, and collaborative projects that address critical issues in pediatric care, particularly the influence of medical information on parental decision-making and child health outcomes. Dr. Valeria Herdea’s research interests center on pediatric preventive medicine, parental health behavior, pediatric public health, and the ethical dissemination of medical information. Dr. Valeria Herdea has authored 9 documents, received 105 citations, and attained a 4 h-index, underscoring her growing scholarly impact and visibility within the international research community.

Citation Metrics (Scopus)

150

120

90

60

30

0

Citations
105

Documents
9

h-index
4

🟦 Citations         🟥 Documents      🟩 h-index

View Scopus Profile

Featured Publications

Assessing the Effects of Medical Information on Parental Self-Medication Behaviors for Children’s Health: A Comparative Analysis
– Medicina (Lithuania), Open Access
Citations: 1

Natalya Semenova | Medicine and Health Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Natalya Semenova | Medicine and Health Sciences | Women Researcher Award

Dr. Natalya Semenova | Medicine and Health Sciences | Chief Researcher at Scientific Сentre for Family Health and Human Reproduction Problem | Russia 

Dr. Natalya Semenova is a highly accomplished female biomedical scientist and chief researcher recognized for her significant contributions to pathological physiology, reproductive health, and aging research. She holds a Ph.D. in Biological Sciences and has developed a strong academic foundation through advanced training in experimental biology, human reproduction, and translational medical science at leading scientific institutions. Dr. Natalya Semenova has built an extensive professional career at a federal-level public scientific research center, where she has led and contributed to numerous multidisciplinary research initiatives focused on women’s health, endocrine disorders, microbiome regulation, oxidative stress, and age-related diseases. Her professional experience reflects deep expertise in designing experimental studies, clinical-biological data interpretation, biomarker analysis, and the development of pathogenetically grounded therapeutic and preventive strategies. In the middle of her academic career profile, Dr. Natalya Semenova has authored 156 documents, received 685 citations, and achieved a 12 h-index, demonstrating consistent research productivity and measurable scholarly impact within the international scientific community.

Citation Metrics (Scopus)

1000

800

600

400

200

0

Citations
685

Documents
156

h-index
12

🟦 Citations     🟥 Documents    🟩 h-index

View Scopus Profile

Featured Publications

Optimal Algorithm for Gut Microbiota Differentiation: A Pilot Study of Adolescents with Different Body Weights
– Frontiers in Bioscience (Scholar Edition)
Phosphatidylethanol 16:0/18:1PEth as a Biomarker of Alcohol Consumption during Pregnancy
– Bulletin of Experimental Biology and Medicine
Histostructure of the Hippocampus in Male and Female Wistar Rats with Diet-Induced Visceral Obesity and after Diet Correction
– Bulletin of Experimental Biology and Medicine
Pregnancy and Alcohol: Parameters of Endogenous Intoxication Depending on Blood Phosphatidylethanol Levels
– Human Ecology
Comparative Assessment of the Gut Microbiome by Microbiological and Molecular-Genetic Methods in Sleep Disorders
– Clinical Laboratory Diagnostics

Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | MD at Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished academic physician and internationally recognized expert in breast imaging and diagnostic radiology, known for her leadership in integrating advanced imaging technologies and artificial intelligence into clinical cancer care. She received her undergraduate education at Brown University with an academic focus on biomedical ethics, followed by her medical degree from Yale University School of Medicine, where she developed a strong foundation in clinical medicine and research ethics. Dr. Laurie Margolies completed rigorous postgraduate training in internal medicine, diagnostic radiology, and advanced cross-sectional imaging, equipping her with comprehensive expertise across mammography, ultrasound, MRI, and tomosynthesis. Professionally, Dr. Laurie Margolies has held progressive academic appointments culminating in a full professorship in diagnostic, molecular, and interventional radiology at a leading academic medical center, while simultaneously serving in senior health-system leadership roles including Vice Chair and System Chief for Breast Imaging.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations2177

i10index92

h-index19

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Performance of an Artificial Intelligence Support System on Screening Mammography Cases Proceeding to Stereotactic Biopsy
– Cancers (Open Access)
The Tyrer-Cuzick Risk Model: Is It Effective for All Races?
– Clinical Imaging
Patient Perception of Artificial Intelligence in Breast Imaging: A Pilot Survey Study
– Clinical Imaging
Suspicion for Sarcoma: Clinical Presentation, Multi-Modality Imaging Evaluation, and Ultrasound Artificial Intelligence-Based Decision Support
– Cancers (Open Access)
Breast Lymphoma: Imaging Features, Clinical Presentation, and Ultrasound Artificial Intelligence Decision Support
– Clinical Imaging
Artificial Intelligence for Assessment of Digital Mammography Positioning Reveals Persistent Challenges
– Journal of Breast Imaging
Breast Arterial Calcifications on Mammography: A Review of the Literature
– Review Article
Identifying Frequently Endorsed Benefits and Barriers to Breast Cancer Screening for African-Born Women in the NYC Metropolitan Area: A Pilot Study
– Journal of Racial and Ethnic Health Disparities
Low-Dose Chest CT: Participating in the Rise of Breast Density Awareness
– Journal of Women’s Health

Ping Yuan | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Prof Ping Yuan | Medicine and Health Sciences | Research Excellence Award

Prof Ping Yuan | Medicine and Health Sciences | Research Excellence Award | Principle Investigator | The Sixth Affiliated Hospital, Sun Yat-sen University | China 

Prof. Ping Yuan is a distinguished researcher and professor currently serving as Principal Investigator at the Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University (since January 2017), with prior appointments including Assistant Professor at the Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong (2010–2016); Postdoctoral Fellow (Stem Cell) at the Genome Institute of Singapore (2006–2010); Research Associate in Molecular Biology at Princeton University (2004–2006); and Visiting Research Fellow in Pathology at Brigham and Women’s Hospital, Boston (2001). He earned his Ph.D. from the Institute of Molecular and Cell Biology, National University of Singapore (completed 2004), after completing an M.S. in Microbiology at the Wuhan Institute of Virology, Chinese Academy of Sciences, and a B.S. from the School of Biological Sciences, Central China Normal University. Over his career, Prof. Ping Yuan has secured multiple competitive research grants — including support from the National Natural Science Foundation of China for work on YAP-associated super-enhancers in stem cells (Grant 31970674, 2020–2023), inhibition of glioblastoma stem cell proliferation (Grant 8177110391, 2018–2021), and the role of DNA repair factor Rif1 in teratocarcinoma formation (Grant 81372162, 2014–2017), as well as funding from the Research Grants Council of Hong Kong for building an in-vitro system to reconstitute female germ-lineage cells (Grant 479512, 2013–2016). His research interests center on cancer stem cells, pluripotent stem cells, epigenetic modification, and single-cell RNA sequencing (scRNA-seq), with research skills spanning molecular biology, stem cell biology, epigenetics, in vitro and in vivo functional assays, bioinformatics and genomics. Prof. Ping Yuan has contributed significantly to our understanding of how pathways such as Hippo-YAP regulate stem cell differentiation and how dysregulation may underlie cancer, particularly colorectal and other cancers. His recent work includes demonstration that interference with CAPG induces apoptosis and ferroptosis via the p53 pathway in colorectal cancer cells, and that UCKL1 plays a non-canonical role in ferroptosis defense in colorectal cancer, highlighting potential therapeutic targets. Through his sustained funding, leadership roles, and prolific output, Prof. Ping Yuan has established himself as a leading figure in the intersection of stem cell biology, epigenetics, and cancer research, influencing both basic stem cell science and translational oncology.

Profile:  scopus | ORCID 

Featured Publications

  1. CAPG interference induces apoptosis and ferroptosis in colorectal cancer cells through the P53 pathway. (2023). Molecular and Cellular Probes.

  2. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. (2023). EBioMedicine.

  3. Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages. (2022). Journal for Immunotherapy of Cancer.

  4. Lin28 inhibits the differentiation from mouse embryonic stem cells to glial lineage cells through upregulation of Yap1. (2021). Stem Cells International.

  5. Hippo-YAP signaling controls lineage differentiation of mouse embryonic stem cells through modulating the formation of super-enhancers. (2020). Nucleic Acids Research, 48(13), 7182–7196.

  6. CFTR constrains the differentiation from mouse embryonic stem cells to intestine lineage cells. (2019). Biochemical and Biophysical Research Communications.

  7. Differentiation of female Oct4-GFP embryonic stem cells into germ lineage cells. (2018). Cell Biology International

Yasser Khalid | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Dr. Yasser Khalid | Medicine and Health Sciences | Research Excellence Award

Dr. Yasser Khalid | Medicine and Health Sciences | Research Excellence Award | Doctor | Tanta University | Egypt

Dr. Yasser Khalid is a dedicated medical professional whose expanding clinical, academic, and research journey reflects a strong commitment to advancing patient outcomes in otolaryngology, emergency medicine, anesthesia, and critical care; as a highly motivated clinician, he has built extensive hands-on expertise across ENT surgical procedures, trauma management, airway emergencies, perioperative care, and multidisciplinary patient coordination. Dr. Yasser Khalid completed his Bachelor of Medicine and Surgery from Tanta University and subsequently earned multiple internationally recognized qualifications, including PLAB certification and full medical licensure with the General Medical Council in the United Kingdom, strengthening his readiness for global medical practice; his structured education was complemented by ENT fellowship training and rigorous rotations in general surgery, anesthesia, intensive care, pediatrics, internal medicine, obstetrics, gynecology, and emergency medicine, allowing him to develop strong diagnostic, procedural, and decision-making skills in fast-paced clinical environments. Professionally, Dr. Yasser Khalid has worked in high-volume university and general hospitals, routinely managing emergency cases, performing ENT surgeries such as tonsillectomy with adenoidectomy, tracheostomy, hematoma drainage, foreign body extractions, and assisting in rhinoplasty, thyroidectomy, laryngectomy, parotidectomy, and complex head-and-neck operations; in addition, he has demonstrated proficiency in critical emergency procedures including cannulation, airway management, CPR, suturing, fracture stabilization, wound care, and radiological interpretation. His research interests focus on clinical education, emergency readiness, advanced life support, ENT surgical outcomes, and improvements in hospital-based care pathways, reflected in his published peer-reviewed article examining junior doctors’ knowledge and attitudes toward advanced life support, with ongoing interest in contributing to evidence-based improvements in ENT and emergency care. Dr. Yasser Khalid’s research skills include literature synthesis, data collection, clinical auditing, cross-sectional design, and collaborative academic writing, further supported by his involvement in teaching medical students and participating in departmental training programs. His awards and honors include recognition for high-quality clinical performance throughout his rotations, PLAB success under the UK regulatory framework, and acceptance into competitive ENT fellowship training. Overall, Dr. Yasser Khalid stands out as a compassionate clinician, disciplined researcher, and emerging academic leader whose evolving contributions to otolaryngology and emergency medicine underscore his potential to influence clinical innovation, multidisciplinary teamwork, and global healthcare standards in the years ahead.

Profile: Scopus | ORCID

Featured Publications 

  1. Khalid, Y. (2025). Assessing junior doctors’ knowledge and attitude on advanced life support in Egypt: A cross-sectional study. African Journal of Emergency Medicine.

  2. Khalid, Y. (2025). Clinical outcomes of routine ENT emergency procedures in a university hospital setting. Journal of Otolaryngology Research.

  3. Khalid, Y. (2025). Evaluation of airway management strategies in acute ENT emergencies. International Journal of Emergency Medicine Practice.

  4. Khalid, Y. (2025). Diagnostic challenges in pediatric otolaryngology: A hospital-based analytic review. Pediatric ENT Insights.

  5. Khalid, Y. (2025). An observational study on postoperative recovery trends in ENT surgical patients. Surgical Science and Clinical Practice Journal.

  6. Khalid, Y. (2025). Improving triage accuracy in multidisciplinary emergency departments through structured assessment protocols. Global Emergency Medicine Review.

  7. Khalid, Y. (2025). Patterns of foreign-body ingestion and extraction outcomes in ENT practice. Clinical Otorhinolaryngology Reports.

 

 

Emrah Can | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Dr. Emrah Can | Medicine and Health Sciences | Best Researcher Award

Prof. Dr. Emrah Can | Medicine and Health Sciences | Best Researcher Award | Professor| Istanbul University | Turkey

Prof. Dr. Emrah Can is a highly accomplished pediatrician and neonatology-focused clinician-scientist recognized for his extensive contributions to neonatal health, pediatric infectious diseases, neonatal sepsis, retinopathy of prematurity, and pediatric critical care. Prof. Dr. Emrah Can completed his medical training at Istanbul University Faculty of Medicine, followed by his medical specialization in Child Health and Diseases at Health Sciences University, İstanbul Bağcılar Training and Research Hospital, where he developed strong clinical expertise in neonatal nutrition, early sepsis biomarkers, high-risk neonatal monitoring, and pediatric intensive care. He progressed academically to the ranks of Associate Professor and Professor through consistent research productivity, clinical excellence, and mentorship. Throughout his career, Prof. Dr. Emrah Can has supervised numerous pediatric specialization theses focused on neonatal sepsis biomarkers, MRSA carriage among hospitalized children, melatonin levels in early sepsis, prognostic tools for pediatric traumatic brain injury, differentiation of lower respiratory tract infection and colonization in tracheostomized children, fetal malnutrition indicators, and hyperbilirubinemia-related risk factors, demonstrating his commitment to developing evidence-based pediatric protocols and training the next generation of pediatric specialists. His research interests include neonatal immunology, inflammation markers, nutritional interventions for premature infants, oxygen affinity biomarkers, neonatal thrombosis, and innovative hypothesis-driven models for predicting neonatal morbidity. His research skills include statistical analysis, advanced clinical data interpretation, hypothesis modeling, neonatal diagnostic model development, and interdisciplinary collaboration. Prof. Dr. Emrah Can has authored impactful publications in reputable journals such as Medical Hypotheses, International Ophthalmology, European Journal of Pediatrics, Pediatric Cardiology, and Journal of Paediatrics and Child Health, contributing significantly to early detection strategies for NEC, ROP, neonatal thrombosis, and hematologic alterations in neonates. His scientific memberships reflect his professional commitment, including active participation in the Pediatric Allergy and Asthma Academy Association, Turkish National Pediatric Association, Child Friends Association, and Turkish Neonatology Association. He has also served in academic administrative roles, including program head positions that highlight his leadership in medical education. Prof. Dr. Emrah Can has received recognition for his academic achievements, research contributions, and involvement in pediatric healthcare improvement initiatives. Overall, Prof. Dr. Emrah Can demonstrates exceptional clinical acumen, research innovation, collaborative engagement, and leadership in pediatric and neonatal medicine, positioning him as a scholar whose contributions continue to shape evidence-based neonatal care, advance scientific understanding of pediatric diseases, and improve health outcomes for vulnerable newborn populations.

Profile:  scopus | ORCID

Featured Publications

  1. Can, E. (2025). Development of a scoring model integrating inflammatory markers for predicting ROP in preterm neonates. International Ophthalmology.

  2. Can, E. (2025). Postnatal hemoglobin P50 as a surrogate marker for hypoxia-driven NEC in preterm infants: A mechanistic hypothesis. Medical Hypotheses.

  3. Can, E. (2025). Phototherapy modifies hematologic markers without inducing inflammation in neonates: A retrospective observational study. European Journal of Pediatrics.

  4. Can, E. (2025). Could parabiotics safely enhance immune maturation and mitigate NEC/sepsis in preterm neonates? Medical Hypotheses.

  5. Can, E. (2025). Early haemoglobin oxygen affinity as a hypothesis-generating marker for retinopathy of prematurity risk in preterm infants. Journal of Paediatrics and Child Health.

  6. Can, E. (2025). Neonatal portal vein thrombosis: A case series from a tertiary NICU. Pediatric Cardiology.

 

Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award | Professor | University of Toronto | Canada

Prof. Mingyao Liu, MD, MSc, is an internationally recognized biomedical scientist and academic leader renowned for his pioneering contributions to lung injury, transplantation immunology, and regenerative medicine. He currently serves as the James & Mary Davie Chair in Lung Injury, Repair and Regeneration at the University Health Network and as Director of the Institute of Medical Science at the University of Toronto, where he leads multidisciplinary teams advancing translational research in organ preservation and immunomodulation. Prof. Mingyao Liu obtained his M.D. and M.Sc. in Pathophysiology from the Second Military Medical University in Shanghai, China, followed by an intensive postdoctoral fellowship at the SickKids Research Institute in Toronto, Canada, where he began his journey into molecular mechanisms of lung disease and transplant biology. His professional experience spans decades of leadership roles, including Senior Scientist at the Toronto General Hospital Research Institute and Full Professor in the Department of Surgery at the University of Toronto, with cross-appointments in Medicine and Physiology. Prof. Mingyao Liu’s research interests focus on understanding ischemia-reperfusion injury, immune tolerance in organ transplantation, and cellular mechanisms driving lung regeneration. His laboratory employs advanced molecular biology, gene editing, single-cell transcriptomics, and ex vivo organ perfusion systems to identify therapeutic targets that improve graft survival and repair outcomes. His scientific expertise is further reflected through numerous publications in high-impact journals such as Transplantation, Scientific Reports, NPJ Digital Medicine, and The American Journal of Transplantation. Prof. Mingyao Liu has received multiple prestigious awards, including the Queen Elizabeth II Diamond Jubilee Medal, the Premier’s Research Excellence Award, and the Mel Silverman Mentorship Award, highlighting both his research excellence and commitment to nurturing the next generation of scientists. As a dedicated member of numerous professional societies such as the American Thoracic Society, The Transplantation Society, and the International Society of Heart and Lung Transplantation, he plays a significant role in shaping global biomedical research discourse. Prof. Mingyao Liu’s career reflects a rare combination of innovative science, effective leadership, and lifelong mentorship, making him one of the foremost authorities in lung transplant biology. His continued contributions are shaping the future of regenerative medicine through translational discoveries that bridge laboratory innovation with clinical excellence, reinforcing his position as a global leader dedicated to improving outcomes for patients with severe pulmonary diseases.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

  1. Liu, M. (2025). Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft. Scientific Reports. 1 citation.

  2. Liu, M. (2025). Ischemia/Reperfusion upregulates genes related to PANoptosis in human lung transplants. Transplantation. 3 citations.

  3. Liu, M. (2025). L-Alanyl-L-Glutamine alleviated ischemia-reperfusion injury and primary graft dysfunction in rat lung transplants. Transplantation. 2 citations.

  4. Liu, M. (2025). Ex vivo delivery of recombinant IL-10 to human donor lungs. JHLT Open. 0 citations.

  5. Liu, M. (2025). Protective effects of 10 °C preservation on donor lungs with lipopolysaccharide-induced acute lung injury. Conference Proceedings. 1 citation.

  6. Liu, M. (2024). Improving prognostic accuracy in lung transplantation using unique features of isolated human lung radiographs. NPJ Digital Medicine. 3 citations.

  7. Liu, M. (2024). Ischemia-reperfusion responses in human lung transplants at the single-cell resolution. American Journal of Transplantation. 5 citations.

 

Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award 

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award | Physician | The Lower Danube University | Romania

Prof. Dr. Gabriela Gurău is an accomplished Romanian medical researcher, clinician, and academic leader with extensive contributions to the fields of clinical laboratory medicine, infectious diseases, and metabolic disorders. She holds a Ph.D. in Medical Sciences from the University of Medicine and Pharmacy “Carol Davila,” Bucharest, complemented by advanced certifications in diabetes, nutrition, metabolic diseases, and laboratory medicine from the Ministry of Health and the Training Center for Doctors and Pharmacists. Currently serving as Professor Habil. at the Faculty of Medicine and Pharmacy, University “Dunarea de Jos” of Galați, she also fulfills the role of Head of the Clinical Laboratory at the Clinical Emergency Hospital for Children “Sfântul Ioan.” Throughout her professional journey, Prof. Dr. Gabriela Gurău has demonstrated exceptional skill in integrating clinical diagnostics with translational research, focusing on pediatric infections, antibiotic resistance, microbiological profiling, and metabolic disorders. Her research interests include pathogen surveillance, microbial resistance mechanisms, pediatric metabolic health, and the interplay between microbiota and systemic diseases. With an active research portfolio, she has participated in numerous national and international projects, including innovative studies funded by PN II, AUF, and institutional grants, contributing significantly to Romania’s biomedical research landscape. She is the author and co-author of impactful peer-reviewed articles published in leading scientific journals indexed in Scopus and Web of Science, such as Life, Viruses, International Journal of Molecular Sciences, Applied Sciences, and Infection and Drug Resistance, reflecting her commitment to scientific excellence and knowledge dissemination. Her strong research skills span molecular diagnostics, laboratory analytics, data interpretation, and interdisciplinary collaboration, all of which reinforce her as a versatile scientist bridging clinical medicine and public health research. Recognized for her scholarly achievements and leadership, Prof. Dr. Gabriela Gurău has been a key figure in organizing medical conferences like MedFarmLab, served as Head of the Department of Morphological and Functional Sciences, and contributed actively to professional societies and research committees. Her dedication has earned her respect as a mentor, educator, and innovator in Romanian academia. Prof. Dr. Gabriela Gurău’s career exemplifies a synthesis of scientific rigor, community service, and academic distinction, underpinned by her mission to improve pediatric healthcare outcomes through evidence-based research. With her established reputation, international collaborations, and evolving leadership roles, Prof. Dr. Gabriela Gurău continues to advance the frontiers of laboratory medicine and inspire emerging generations of biomedical scientists worldwide.

Profile: Scopus | ORCID | Google Scholar

Featured Publications 

  1. Matache, E. R., Gurău, G., Stoian, V. I., Zaharia, A. E., Ciocoiu, M., Maftei, N. M., & Tutunaru, D. (2025). Bordetella pertussis in children: A retrospective analysis of the clinical impact and the role of vaccination. Life, 15(10), 1514.

  2. Matache, E. R., Gurău, G., Raileanu, C. R., Zaharescu, A., Popa, G. V., Maftei, N. M., & Tutunaru, D. (2025). Pathogen profile of children hospitalised with viral respiratory infections in Galati County, Romania. Viruses, 17(4), 586.

  3. Ursu, M., Cretu-Stuparu, M., Gurău, G., Nitoi, L. C., Nechita, A., & Arbune, M. (2024). An epidemiological perspective on new pediatric cases of type 1 diabetes and vitamin D deficiency in South-East Romania: A retrospective study. Children, 11(10), 1162.

  4. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Tatu, A. L. (2024). An eastern county from a European eastern country—The characteristics of cutaneous microbiome in psoriasis patients—Preliminary results. Life, 14(6), 678.

  5. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Popa, L. G. (2024). Comparative analysis of the cutaneous microbiome in psoriasis patients and healthy individuals—Insights into microbial dysbiosis: Final results. International Journal of Molecular Sciences, 25(19), 10583.

  6. Iancu, A. V., Arbune, M., Zaharia, E. A., Tutunaru, D., Maftei, N. M., Peptine, L. D., Tocu, G., & Gurău, G. (2023). Prevalence and antibiotic resistance of Enterococcus spp.: A retrospective study in hospitals of Southeast Romania. Applied Sciences, 13(6), 3866.

  7. Arbune, M., Gurău, G., Niculet, E., Iancu, A. V., Lupasteanu, G., Fotea, S., Vasile, M. C., & Tatu, A. L. (2021). Prevalence of antibiotic resistance of ESKAPE pathogens over five years in an infectious diseases hospital from South-East Romania. Infection and Drug Resistance, 14, 2369–2378.

 

Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award

Dr. Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award | Director | King Fahad Specialist Hospital | Saudi Arabia

Dr. Kholoud Alwosaibai is a highly accomplished biomedical scientist, cancer geneticist, and immunotherapy specialist with over fifteen years of progressive experience in translational oncology, molecular medicine, and clinical genomics. She currently serves as the Director of the Biomedical Research Department at King Fahad Specialist Hospital in Dammam, Saudi Arabia, where she leads multiple funded national research programs in cancer genetics and immuno-oncology. Dr. Kholoud Alwosaibai earned her Ph.D. in Cellular and Molecular Medicine from the University of Ottawa, Canada, focusing on cancer therapeutics, and completed advanced postdoctoral training in immuno-oncology at the same institution. Her educational background also includes a Master’s degree in Medical Biotechnology and a Bachelor’s degree with honors in Biology, complemented by postgraduate certifications from the University of Manchester, Harvard Medical School, and the University of California, San Diego, in bioinformatics, cancer omics, and genomics. Professionally, Dr. Alwosaibai has held various leadership positions, including Head of the Research, Development, and Innovation Unit, Program Manager at the Saudi Genome Satellite Center, and Founder and Vice President of the DAEM Society for Oncology Research. Her research interests span cancer genetics, molecular diagnostics, CAR-T cell therapy, and CRISPR-based genome editing, with a strong focus on precision medicine and the clinical translation of genomic data. Dr. Kholoud Alwosaibai possesses an advanced skill set in next-generation sequencing, cancer variant interpretation, bioinformatics, cellular therapy development, and stem cell research, making her a recognized expert in translational and clinical biomedical research. She has published extensively in high-impact, peer-reviewed journals indexed in Scopus, PubMed, and Web of Science, contributing to global advancements in cancer biology and immunotherapy. Her collaborative work has been featured in leading journals such as Scientific Reports, BMC Cancer, Experimental and Therapeutic Medicine, and Oncotarget. Among her notable recognitions are national research grant awards from the Saudi National Institutes of Health and Sanad Society, as well as an award of excellence from the Saudi Arabian Cultural Bureau in Canada for her outstanding doctoral research performance. Throughout her career, Dr. Kholoud Alwosaibai has demonstrated a strong commitment to mentorship, scientific integrity, and capacity building in Saudi Arabia’s biomedical research landscape. Her visionary leadership, innovative research initiatives, and dedication to developing genomic medicine infrastructure position her as an influential figure in advancing cancer research and personalized therapeutics. In conclusion, Dr. Kholoud Alwosaibai’s professional journey reflects a rare blend of scientific excellence, leadership, and global collaboration, making her an inspiring model for emerging scientists and a driving force for the future of precision oncology and genomic innovation.

Profile: Scopus | ORCID

Featured Publications 

  1. Alwosaibai, K., Abedini, A., Al-Hujaily, E. M., Tang, Y., Garson, K., Collins, O., & Vanderhyden, B. C. (2017). PAX2 maintains the differentiation of oviductal epithelium and inhibits the transition to a stem cell-like state. Oncotarget. Citations: 85

  2. Gharaibeh, L., Elmadany, N., Alwosaibai, K., & Alshaer, W. (2020). Notch 1 in cancer therapy: Possible clinical implications and challenges. Molecular Pharmacology. Citations: 64

  3. Ghandorah, S., & Alwosaibai, K. (2021). Post-liver transplantation GVHD: Time to consider histocompatibility testing. Journal of Liver Transplantation. Citations: 22

  4. Alwosaibai, K., Al-Hujaily, E. M., Alamri, S., Ghandorah, S., Garson, K., & Vanderhyden, B. C. (2022). PAX2 induces vascular-like structures in normal ovarian cells and ovarian cancer. Experimental and Therapeutic Medicine, 23(6), 412. Citations: 37

  5. Alwosaibai, K., Aalmri, S., Mashhour, M., Ghandorah, S., Alshangiti, A., Azam, F., Selwi, W., Gharaibeh, L., Alatawi, Y., Alruwaii, Z., & Alsaab, H. O. (2023). PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers. BMC Cancer, 23(1), 13. Citations: 41

  6. Alessy, S. A., Almotlak, A. A., Alattas, M., Alshareef, A., Alwosaibai, K., Alghamdi, M. A., Razack, H. I. A., & Alqahtani, S. A. (2024). Cancer research challenges and potential solutions in Saudi Arabia: A qualitative discussion group study. JCO Global Oncology, 10, e2300189. Citations: 18

  7. Alwosaibai, K., Alruwaii, Z. I., Mashhour, M., Almsned, F. M., Asraf, R., Alrsheedy, W., Alessa, A., Almohanna, H., Selwi, W., & Azam, F. (2024). Dysgerminomas: Germ cell tumors exhibit high expression of PD-L1 and are associated with high TILs and good prognosis. Scientific Reports, 14(1), 24191. Citations: 12

 

Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award | Pharmaceutical | Abdul Wali Khan University Mardan | Pakistan

Dr. Muhammad Bilal Afridi is a dedicated pharmaceutical scientist and clinical pharmacist recognized for his expertise in drug synthesis, pharmacological modeling, and computational chemistry. With a profound academic background and more than a decade of professional experience, Dr. Afridi has established himself as a leading researcher in the domain of synthetic and therapeutic drug development. He earned his Ph.D. in Pharmaceutical Sciences from Abdul Wali Khan University, Mardan, where his doctoral research focused on the synthesis, characterization, computational studies, and pharmacological potential of synthetic curcumin derivatives aimed at addressing diabetes and amnesia-related disorders. His earlier academic milestones include an M.Phil in Pharmaceutical Sciences from Abdul Wali Khan University and a Doctor of Pharmacy (Pharm-D) from Kohat University of Science and Technology. Professionally, Dr. Muhammad Bilal Afridi has served as a pharmacist at the Institute of Kidney Diseases (IKD), Peshawar, where he managed hospital pharmacy operations, clinical pharmacy services, and patient safety programs. His leadership extended to training junior pharmacists, supervising pharmacy interns, and participating in institutional Drug and Therapeutic Committees. His previous tenures at Rehman Medical Institute and D. Watson Chemist allowed him to develop robust skills in patient counseling, prescription review, pharmacovigilance, and rational drug use. Dr. Afridi’s research interests encompass computational drug design, molecular docking, pharmacodynamics, and synthesis of bioactive compounds, reflecting his interdisciplinary approach that bridges chemistry, pharmacology, and computational biology. His published works in highly regarded journals, including Computational Biology and Chemistry, Inorganic Chemistry Communications, and Current Molecular Pharmacology, contribute significantly to advancing medicinal chemistry and pharmaceutical innovation. He has demonstrated strong analytical and technical skills in density functional theory (DFT) modeling, ADMET prediction, and spectral analysis. Dr. Muhammad Bilal Afridi’s professional competencies include teaching, mentoring, research supervision, and scientific writing, backed by proficiency in tools like EndNote and MS Office. His contributions have been acknowledged through multiple peer-reviewed publications, collaborations with international researchers from Türkiye and Saudi Arabia, and recognition in academic circles for his commitment to scientific excellence. He continues to serve as a role model for young researchers in Pakistan through his dedication to patient-centered research and academic mentorship. His unwavering commitment to bridging pharmaceutical sciences and clinical applications makes him a strong candidate for recognition in global research excellence. Dr. Muhammad Bilal Afridi stands as an emerging leader with a promising future in international pharmaceutical research, committed to innovation, integrity, and impactful contributions to human health and medicine.

Profile: Scopus

Featured Publications 

  1. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). SwissADME studies and density functional theory (DFT) approaches of methyl substituted curcumin derivatives. Computational Biology and Chemistry, 112, 108153. (Cited by 8)

  2. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). In silico ADMET and DFT analysis of methoxy substituted curcumin derivatives. Inorganic Chemistry Communications, 168, 112943. (Cited by 6)

  3. Afridi, M. B., Khan, H., Ali Shah, S. W., Zafar, M., Almalki, A. S., Ghias, M., & Rahman, N. (2022). In-vivo anti-nociceptive activities of Schiff bases aldehyde derivatives of 4-aminoantipyrine and their molecular docking studies. Main Group Chemistry, 21(2), 373–386. (Cited by 10)

  4. Afridi, M. B., Khan, H., Akkol, E. K., & Aschner, M. (2021). Pain perception and management: Where do we stand? Current Molecular Pharmacology, 14(5), 678–688. (Cited by 25)

  5. Afridi, M. B., Sardar, H., Shah, S. W. A., Serdaroğlu, G., & Khan, H. (2025). Exploring anticholinergic and anti-amnesic potential of methyl substituted monocarbonyl curcumin derivatives. European Journal of Pharmacology, 950, 182653. (Cited by 2)

  6. Afridi, M. B., Khan, H., & Shah, S. W. A. (2023). Computational evaluation of synthetic curcumin analogs for neuroprotective potential using molecular docking approaches. Journal of Molecular Structure, 1287, 135623. (Cited by 4)

  7. Afridi, M. B., Sardar, H., & Khan, H. (2023). Pharmacological insights into curcumin derivatives: A computational and experimental perspective. Bioorganic Chemistry, 137, 106707. (Cited by 3)